Efficacy Trial of the CALM Intervention

December 4, 2024 updated by: Golda S. Ginsburg, UConn Health

Enhancing the Capacity of School Nurses to Reduce Excessive Anxiety in Children: an Efficacy Trial of the CALM Intervention

Excessive anxiety among elementary students is highly prevalent and associated with impairment in academic, social, and behavioral functioning. The primary aim of this project is to evaluate the initial efficacy of a brief nurse-delivered intervention (CALM: Child Anxiety Learning Modules), relative to a credible comparison (CALM-R, relaxation skills only) and a waitlist control for reducing anxiety symptoms and improving education outcomes at post intervention and at a 1-year follow-up. In addition, the research team will assess the cost effectiveness of CALM versus CALM-R and the waitlist control and examine potential predictors, moderators, and mediators of CALM's impact on child outcomes based on the proposed theory of change.

Study Overview

Detailed Description

Excessive anxiety among elementary age students is common, severely impairs academic, social, and behavioral functioning, and is associated with significant educational and health care costs. Despite the high burden of anxiety, less than half of children with anxiety receive the services they need to succeed in school. School clinicians can and do support these youth, however, their caseloads are high and their time to provide individualized services is limited. Consequently, there is a critical need to expand the network of providers who can assist students with anxiety and address this malleable obstacle to student academic success. Because somatic complaints, such as headaches and stomach aches, are a hallmark feature of excessive anxiety, school nurses are often the first school-based personnel to identify problematic anxiety in students. However, school nurses currently lack training in evidenced-based anxiety reduction interventions. The current study leverages findings from a three-year IES Development award (R305A140694), through which our team developed and assessed the feasibility of training elementary school nurses to use a brief intervention to reduce student anxiety; it was demonstrated that the training and intervention (i.e., Child Anxiety Learning Modules; CALM) was indeed feasible to implement and resulted in positive changes in student outcomes. CALM is now a fully developed intervention with ready-to-use intervention components and materials, training and coaching procedures, and is ready for an initial efficacy evaluation in authentic school settings. Toward that end, the primary purpose of this study is to evaluate the efficacy of CALM in a fully powered randomized controlled trial. CALM will be delivered by elementary school nurses in rural, suburban, and urban elementary schools nationwide to enhance the generalizability of findings across socioeconomic, racial, ethnic, and neighborhood settings (as approximately 80% of schools in the US have a school nurse). The efficacy of CALM will be tested using gold standard methods (e.g., independent evaluators to assess primary outcomes). The study's primary aim is to evaluate the efficacy of CALM, compared to a credible comparison condition (CALM-R; a school nurse delivered relaxation skills only intervention that parallels CALM in time and format) as well as a waitlist control, for reducing anxiety symptoms and improving educational outcomes at post-intervention and a one year follow-up. The secondary aim is to examine the cost effectiveness of CALM relative to CALM-R and the waitlist control. An exploratory aim is to examine potential predictors, moderators, and mediators of student outcomes based on the proposed theory of change. If efficacious, CALM will be the first evidenced-based school nurse delivered intervention to assist youth with excessive anxiety, filling an important gap in current practices.

Study Type

Interventional

Enrollment (Estimated)

218

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Connecticut
      • West Hartford, Connecticut, United States, 06119
        • Recruiting
        • University of Connecticut School of Medicine
        • Contact:
        • Contact:
        • Contact:
          • Golda Ginsburg
    • Maryland
      • Columbia, Maryland, United States, 21045
        • Recruiting
        • Anxiety Treatment Center of Maryland
        • Contact:
        • Contact:
          • Phone Number: 6786176562
        • Contact:
          • Kelly Drake, Ph.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 12 years (Child)

Accepts Healthy Volunteers

No

Description

Student Inclusion Criteria:

  • Be between the ages of 5-12
  • Have elevated anxiety symptoms as indicated by a) a total SCARED score of 15 or higher based on parent and/or child report using the full SCARED from the baseline evaluation, and/or b) a Clinician Severity Rating of 3 or higher on any anxiety diagnosis from the Anxiety Disorders Interview Schedule for Children DSM-V (ADIS)
  • Be fluent in English in order to provide informed consent and assent for their participation and to complete the study measures.
  • Children on a stable dose of pharmacological/psychotherapeutic treatment will be eligible as long as the dose has been stable for at least 4 weeks and no changes are considered for the duration of the intervention phase of the study (8 weeks)

Student Exclusion Criteria:

  • Children who do not meet the inclusion criteria

Nurse Inclusion Criteria:

  • Nurses must be a Registered Nurse (RN) or another similar medical professional
  • Nurses must be work in the role of a school nurse
  • Nurses must be fluent in English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Child Anxiety Learning Modules (CALM)
Children randomly assigned to this condition will receive the CALM intervention.
CALM is a cognitive-behavioral intervention for childhood anxiety. CALM consists of five modules. The primary components include psychoeducation, relaxation training (C), behavioral exposure (A), cognitive restructuring (L), and relapse prevention (M). There is also an optional parent psychoeducation module. Students randomized to the CALM condition will receive the 5 modules over 8 weeks.
Active Comparator: Child Anxiety Learning Modules--Relaxation (CALM-R)
Children randomly assigned to this condition will receive the CALM-R intervention.
CALM-R serves as an active comparison condition to CALM and consists of 5 modules of relaxation skills. The key components of CALM-R include psychoeducation, deep breathing, progressive muscle relaxation, guided imagery, and relapse prevention. Students randomized to the CALM-R condition will receive the 5 modules over 8 weeks.
No Intervention: Waitlist control
Within each nurse, 20% (1 in 5) children will be randomly assigned to wait a period of eight weeks prior to starting the intervention with their school nurse. During this period, the child is not prevented from seeing the school nurse, nor are they prevented from continuing to utilize stable doses of community treatment (i.e., therapy outside of school or medication); nurses are simply asked to provide normal support and avoid using techniques specific to CALM or CALM-R. After the 8 weeks, youth are re-evaluated and nurses begin delivering the intervention to the student.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Global Impression - Impairment (CGI-I) Scale, 8 weeks after baseline
Time Frame: 8 weeks after baseline
The CGI-I provides a global rating of improvement in anxiety, relative to baseline. The measure yields a single rating of clinical improvement during the past week, relative to the baseline rating. Scores range from 1 (very much improved) to 7 (very much worse).
8 weeks after baseline
Clinical Global Impression - Impairment (CGI-I) Scale, 12-month follow-up
Time Frame: 12-month follow-up
The CGI-I provides a global rating of improvement in anxiety, relative to baseline. The measure yields a single rating of clinical improvement during the past week, relative to the baseline rating. Scores range from 1 (very much improved) to 7 (very much worse).
12-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Children's Somatization Inventory (CSI-24)
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The CSI-24 is a is 24-item child- and parent-report measure of the child's somatic symptoms. Parents and children respond to the items using a 5-point scale ranging from "not at all" to "a whole lot." One total score calculated by summing the items. Items are scored 0-4 (range: 0-96); higher scores reflect higher levels of subjective severity of somatic symptoms.
Baseline, 8 weeks after baseline, 12-month follow-up
Behavioral Avoidance
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The Behavioral Avoidance form is a 3-item measure assesses how frequently the student avoids specific anxiety provoking situations. The independent evaluator creates a list of the top 3 anxiety-provoking situations and estimates the frequency with which the child avoids those situations over a two week period prior to evaluation. Avoidance for each situation is measured on a 7-point Likert scale, ranging from 1 (never avoid) to 7 (avoid every time).
Baseline, 8 weeks after baseline, 12-month follow-up
Children's Automatic Thoughts Scale (CATS)
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The CATS is a 40-item measure that assesses frequency of students' maladaptive thoughts associated with anxiety. Children respond to items using a 5-point Likert-type scale describing the frequency with which they have had various thoughts over the past week (not at all, sometimes, fairly often, often, all the time). Higher scores reflect greater frequency of negative self-statements. Three scores are derived from the CATS: one total score (20 items, score range 0-80) plus two subscale scores reflecting the content of self-statements: physical threat (10 items, score range 0-40), social threat (10 items, score range 0-40).
Baseline, 8 weeks after baseline, 12-month follow-up
Children's Global Assessment Scale (CGAS)
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The CGAS is a rating scale that indicates a child's global functioning on a scale of 1 (lowest) to 100 (highest). In general, scores below 70 are indicative of increasingly severe impairment in functioning.
Baseline, 8 weeks after baseline, 12-month follow-up
Student Attendance Form
Time Frame: Two weeks prior to the evaluations
The student attendance form is completed by teachers to assess the child's recent (past two weeks) school attendance including number of full and partial days missed as well as the amount of extra time and attention spent on the child.
Two weeks prior to the evaluations
School Attendance and Discipline
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The School Attendance and Discipline form is an 8-item measure completed by parents that collects information regarding absences from school related to emotional/behavioral problems as well as disciplinary actions at school.
Baseline, 8 weeks after baseline, 12-month follow-up
Student school records - attendance
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
Student records will be obtained from the school that will provide information regarding number of absences, tardiness, and early dismissals during the marking period closest to the dates of baseline, 8-weeks after baseline, and 12-month follow up
Baseline, 8 weeks after baseline, 12-month follow-up
Student school records - disciplinary actions
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
Student records will be obtained from the school that will provide information regarding number of referrals for disciplinary action during the marking period closest to the dates of baseline, 8-weeks after baseline, and 12-month follow up
Baseline, 8 weeks after baseline, 12-month follow-up
Student school records - grades
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
Student records will be obtained from the school that will provide information regarding English and math grades, as well as any grade retention during the marking period closest to the dates of baseline, 8-weeks after baseline, and 12-month follow up. Grades will be categorized into 4 categories: below expectations/not meeting expectations/needs more time (D); near expectations/exhibits progress towards meeting expectations/developing (C); meets expectations/consistently evident (B); exceeds expectations (A)
Baseline, 8 weeks after baseline, 12-month follow-up
Student school records - special education
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
Student records will be obtained from the school that will provide information regarding if the student received special education services (i.e., 504 plan and/or IEP) during the marking period closest to the dates of baseline, 8-weeks after baseline, and 12-month follow up
Baseline, 8 weeks after baseline, 12-month follow-up
Subtests from the Woodcock-Johnson Tests -Achievement and Cognitive Batteries (WJ IV)
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
Subtests from the WJ-IV (i.e., reading, math fluency, and digits backwards) will be administered by the IE to measure cognitive factors (e.g., efficiency, speed, working memory) that are believed to be affected by anxiety. Standard scores will be derived for the Reading Sentences Fluency, Math Facts Fluency, and Numbers Reversed subtests. Standard scores reflect the following ability level: <69=very low; 70-79=low; 80-89=low average; 90-110=average; 111-120=high average; 121-130=superior; >131=very superior.
Baseline, 8 weeks after baseline, 12-month follow-up
Strength and Difficulties Questionnaire (SDQ), Teacher and Parent Versions
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The SDQ assesses a range of emotional and behavioral difficulties in children 4-17 years old (e.g., conduct problems, hyperactivity/ inattention, peer relationship problems, and prosocial behaviors). Nine scores can be derived from the SDQ. (1-5) Five subscales, each of which corresponds to 5 domains: emotional symptoms, conduct problems, hyperactivity, peer problems, prosocial problems. Subscale scores are summed. (6) The total score is generated by summing the scores from all the scales except the prosocial scale. (7-8) Externalizing scores (conduct and hyperactivity) and internalizing scores (emotional and peer problems) are also provided. (9) The impact score is a sum of questions reflecting distress and impairment. Subscale scores each range from 0-10. Externalizing and internalizing scores range from 0-20. The total score can range from 0 to 40. The impact score ranges from 0-6. Higher scores indicate higher levels of the behavior in question.
Baseline, 8 weeks after baseline, 12-month follow-up
Teacher Observation of Classroom Adaptation-Checklist Concentration subscale (TOCA-C)
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The TOCA-C concentration subscale is a 7-item subscale of the TOCA that assesses teachers' perceptions of a student's classroom concentration problems. Teachers rate student concentration on a 6-point Likert scale that ranges from "never (1)" to "almost always (6)." Only the Concentration Problems subscale is used in this study. This subscale includes 7 items (range = 7-42). Higher scores on indicate more maladaptive behaviors.
Baseline, 8 weeks after baseline, 12-month follow-up
Academic Competence Evaluation Scale (ACES), short version
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The ACES is a 32-item teacher report measure that assesses classroom skills and behaviors. Each item is rated on a 5 point scale (1 = never, 5= almost always), with the option to indicate that the behavior is not observed (N/O). The measure is divided in 2 main scales: Academic Skills (14, score range 0-70), consisting of Reading/Language Arts (6 items, score range 0-30), Mathematics (4 items, score range 0-20), and Critical Thinking (4 items, score range 0-20); Academic Enablers (18 items, score range 0-90), consisting of Motivation (5 items, score range 0-25), Engagement (4 items, score range 0-20), Study Skills (4 items, score range 0-20), and Interpersonal Skills (5 items, score range 0-25). Higher scores reflect higher abilities.
Baseline, 8 weeks after baseline, 12-month follow-up
Child Anxiety Impact Scale (CAIS)
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The CAIS is a 27-item child- and parent-report measure of anxiety-related interference in social, academic and family functioning. Children and parents respond to items using a 4-point Likert scale (not at all, just a little, pretty much, very much); higher scores represent greater interference of anxiety in child functioning. The CAIS-C has a total score (27 items, score range 0-81) and three subscales: school (10 items, score range 0-30), social (11 items, score range 0-33), and home/family (6 items, score range 0-18).
Baseline, 8 weeks after baseline, 12-month follow-up
School Anxiety Scale - Teacher Report (SAS-TR)
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The SAS is a 16-item teacher questionnaire that assesses anxiety in the school setting, with a specific focus on social and generalized anxiety symptoms relevant to classroom participation. Teachers rate student anxiety on a 4-point Likert scale that ranges from "never (0)" to "always (3)." The SAS-TR contains a total score (16 items, range of 0 to 48) and two subscales: social anxiety (7 items, range of 0-21) and generalized anxiety (9 items, range of 0 to 27). Higher scores represent higher levels of anxiety; scores of 8 and more on the social anxiety, 10 or more on the generalized anxiety, and 17 or more on the total anxiety is considered to represent high anxious condition.
Baseline, 8 weeks after baseline, 12-month follow-up
Clinical Global Impression - Severity (CGI-S) Scale
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The CGI-S provides a global rating of anxiety severity. The measure yields a single rating of anxiety symptom severity during the past week. Scores range from 1 (Normal; Not at all ill) to 7 (Extremely ill)
Baseline, 8 weeks after baseline, 12-month follow-up
Anxiety Disorders Interview Schedule for DSM-V, Parent and Child Versions (ADIS-V)
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The ADIS-V is a structured interview that assesses anxiety diagnoses and severity in youth. Impairment ratings are generated for each diagnosis using the Clinician Severity Rating (CSR, range = 0-8; higher CSRs indicate higher severity of anxiety disorders, a CSR of 4 is required to assign a diagnosis). Diagnoses are derived separately from the child and parent report, which yields a Composite Diagnosis that is one measure used to determine study eligibility.
Baseline, 8 weeks after baseline, 12-month follow-up
Screen for Child Anxiety-Related Emotional Disorders (SCARED), parent and child versions
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The SCARED is a 41-item child- and parent-report measure of anxiety. Youth and parents respond to items using a 3-point Likert-type scale describing the degree to which statements are true (0 = not true or hardly ever true, 1 = somewhat true or sometimes true, 2 = very true or often true). Higher scores represent higher levels of anxiety. Six scores can be derived from the SCARED: one total score (41 items, score range 0-82) plus five subscale scores: panic/somatic (13 items, score range 0-26), generalized anxiety (9 items, score range 0-18), (3) separation anxiety (8 items, score range 0-16), social anxiety (7 items, score range 0-14), and school phobia (4 items, score range 0-8).
Baseline, 8 weeks after baseline, 12-month follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
CALM and CALM-R Intervention Fidelity, Adherence, Differentiation, and Competence
Time Frame: After each session of the CALM or CALM-R intervention is delivered (approximately 1 session of the intervention delivered each week, for up to 8 weeks)
The CALM and CALM-R Intervention Fidelity, Adherence, Differentiation, and Competence forms contain key points/principles that should be covered during each CALM and CALM-R module and assesses whether they were covered (yes/no), the quality of administration (using a 4 point scale where 1 = poor to 4 = very good), and non-specific factors (e. g., maintains a positive working relationship). For adherence, a yes indicates nurses adhere to the manual; no indicates nurses did not adhere for that particular item. For quality, highest scores indicate greater quality of competence in delivering the intervention components.
After each session of the CALM or CALM-R intervention is delivered (approximately 1 session of the intervention delivered each week, for up to 8 weeks)
Independent Evaluator (IE) masking form
Time Frame: After post (8-week) and follow up (12-month) evaluations
The IE masking form is a 1-item measure that asks the IE to guess the student's intervention assignment in order to assess the integrity of the masking procedures.
After post (8-week) and follow up (12-month) evaluations
Session Summary Form (SSF)
Time Frame: After each session of the CALM or CALM-R intervention is delivered (approximately 1 session of the intervention delivered each week, for up to 8 weeks)
The SSF captures pertinent information about the session such as duration, attendance, intervention strategy, and ratings of the quality of the therapeutic relationship, child compliance, and nurse's perceived competence.
After each session of the CALM or CALM-R intervention is delivered (approximately 1 session of the intervention delivered each week, for up to 8 weeks)
Nurse Background Form
Time Frame: Baseline
The nurse background form assesses demographic characteristics and professional experience (e.g., training, years of experience, license).
Baseline
Maslach Burnout Inventory - General Survey
Time Frame: Baseline, 8 weeks after baseline (with each child), 12-month follow-up
The Maslach Burnout Inventory - General Survey is a 16-item measure completed by nurses that assesses overall levels of burnout on a 6-point likert scale (0=never, 6=every day; scores range from 0-96), with higher scores indicating higher levels of burnout. There are three subscales: exhaustion (5 items, score range 0-30), cynicism (5 items, score range 0-30), and personal efficacy (reverse-scored; 6 items, score range 0-36)
Baseline, 8 weeks after baseline (with each child), 12-month follow-up
Student-Nurse Relationship Scale -Closeness Subscales, student and nurse reports
Time Frame: Baseline, 8 weeks after baseline
The student-nurse relationship scale is a 7-item assesses the quality of the student-nurse relationship on a _-point Likert scale (1=definitely does not apply/is not true, 5=definitely applies/is true); scores range from 7-35), with higher scores indicating a stronger relationship.
Baseline, 8 weeks after baseline
Family demographic form
Time Frame: Baseline
The family demographic form collects information from the parent about the child and the family including age, sex, race, economic status, household family members and parents' marital status.
Baseline
Willingness-to-Pay (WTP) questionnaire
Time Frame: At the conclusion of the CALM study (4 years following the beginning of the study)
The WTP questionnaire obtains a dollar-denominated measure of CALM sites' principals/senior administrator willingness to support the implementation of CALM in their schools and therefore to re-allocate a portion of their budgets to the costs of implementing, operating, and sustaining CALM.
At the conclusion of the CALM study (4 years following the beginning of the study)
Child Health Utility 9-D Index (CHUD)
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The CHUD is a population-based preference-weighted utility index for use in cost-effectiveness analyses. There are a total of 9 dimensions/items (worried, sad, pain, tired, annoyed, schoolwork/homework, sleep, daily routine, and joining in activities) with 5 levels within each dimension. Parents are asked to indicate which level within each dimension is most like their child on the day that they complete the questionnaire. Scores range between 0.33 and 1. Higher scores reflect poorer overall general health-related quality of life.
Baseline, 8 weeks after baseline, 12-month follow-up
Child and Adolescent Services Assessment (CASA)
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
The CASA is a 20-item measure that assesses use of general medical health, mental health, social service, and education services. Items are dichotomous (no=0, yes=1), with checkboxes to indicate details about services (e.g., frequency, indication, provider).
Baseline, 8 weeks after baseline, 12-month follow-up
Parent's missed work form
Time Frame: Baseline, 8 weeks after baseline, 12-month follow-up
This form asks parents to report their total missed days of work due to emotional difficulties of their child.
Baseline, 8 weeks after baseline, 12-month follow-up
Nurse time logs
Time Frame: Baseline, weekly, 8 weeks after baseline, 12-month follow-up
Nurses will complete time logs for each encounter with students enrolled in the study; these logs are used to capture the amount of time spent by the school nurse addressing the needs of the anxious child - at any time - during the active intervention phase (from enrollment through last session). Nurses will record the start and end times of each encounter and a brief checklist of intervention tasks completed, and will also record any other tasks they completed in connection with the encounters, including any communication with school staff members or parents.
Baseline, weekly, 8 weeks after baseline, 12-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Golda S Ginsburg, Ph.D., UConn Health
  • Principal Investigator: Kelly Drake, Ph.D., Johns Hopkins University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2020

Primary Completion (Estimated)

July 3, 2026

Study Completion (Estimated)

July 30, 2026

Study Registration Dates

First Submitted

December 14, 2020

First Submitted That Met QC Criteria

December 31, 2020

First Posted (Actual)

January 5, 2021

Study Record Updates

Last Update Posted (Actual)

December 9, 2024

Last Update Submitted That Met QC Criteria

December 4, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 21-037-2
  • R305A200195 (Other Grant/Funding Number: Institute of Education Sciences)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

  1. Publications: we will submit all publications to the ERIC within 12 months of the publisher's official date of final publication. We will also email copies of publications to interested parties upon request.
  2. Data Access/Sharing: We will provide timely access to the final research data (including data file in SPSS format and a variable codebook). We will share only cleaned, de-identified or synthetic data. These data include surveys/interviews and school records. We will create a data documentation file (i.e., description of all original and derived/summary variables and definitions) to accompany the data file. The documentation will include a description of the study, data collection forms, study protocol/procedures, descriptions of variable recoding performed, and a list of major study publications and investigators.

IPD Sharing Time Frame

The de-identified data and documentation files will be available after the final wave of data are collected, cleaned, and the primary outcome manuscript has been accepted for publication. The data will remain accessible for at least 10 years and the timeframe of data accessibility will be reviewed at the annual progress reviews and revised as necessary.

IPD Sharing Access Criteria

A a CALM Data Request Form will be required from interested individuals. Data will be sent under conditions that the request is reasonable and will be provided to qualified researchers or allied professionals with the necessary skills to use and interpret the data responsibly.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety Disorder of Childhood

Clinical Trials on Child Anxiety Learning Modules (CALM)

Subscribe